Nuveen Asset Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $285K | Hold |
60,438
| – | – | ﹤0.01% | 3138 |
|
|
2024
Q3 | $563K | Sell |
60,438
-7,428
| -11% | -$69.2K | ﹤0.01% | 2976 |
|
|
2024
Q2 | $390K | Buy |
67,866
+13,903
| +26% | +$79.9K | ﹤0.01% | 3074 |
|
|
2024
Q1 | $362K | Hold |
53,963
| – | – | ﹤0.01% | 3060 |
|
|
2023
Q4 | $348K | Buy |
53,963
+483
| +0.9% | +$3.12K | ﹤0.01% | 3113 |
|
|
2023
Q3 | $267K | Hold |
53,480
| – | – | ﹤0.01% | 2986 |
|
|
2023
Q2 | $376K | Hold |
53,480
| – | – | ﹤0.01% | 2972 |
|
|
2023
Q1 | $332K | Sell |
53,480
-483
| -0.9% | -$3K | ﹤0.01% | 2894 |
|
|
2022
Q4 | $345K | Sell |
53,963
-3,090
| -5% | -$19.8K | ﹤0.01% | 2961 |
|
|
2022
Q3 | $490K | Sell |
57,053
-2,551
| -4% | -$21.9K | ﹤0.01% | 2963 |
|
|
2022
Q2 | $811K | Sell |
59,604
-53,270
| -47% | -$725K | ﹤0.01% | 2882 |
|
|
2022
Q1 | $1.52M | Buy |
112,874
+65,887
| +140% | +$887K | ﹤0.01% | 2639 |
|
|
2021
Q4 | $837K | Sell |
46,987
-6,587
| -12% | -$117K | ﹤0.01% | 2914 |
|
|
2021
Q3 | $709K | Sell |
53,574
-2,836
| -5% | -$37.5K | ﹤0.01% | 3098 |
|
|
2021
Q2 | $602K | Buy |
56,410
+44,603
| +378% | +$476K | ﹤0.01% | 3140 |
|
|
2021
Q1 | $156K | Hold |
11,807
| – | – | ﹤0.01% | 3255 |
|
|
2020
Q4 | $239K | Buy |
+11,807
| New | +$239K | ﹤0.01% | 3177 |
|